SNX17 Inhibitors
SNX17 Inhibitors are a class of chemical compounds designed to target and inhibit the function of Sorting Nexin 17 (SNX17), a member of the sorting nexin family involved in endosomal trafficking and receptor recycling. SNX17 plays a crucial role in mediating the endocytosis and subsequent recycling of various cell surface receptors, including integrins and low-density lipoprotein receptors, back to the plasma membrane. By binding to these receptors, SNX17 helps maintain their proper localization and function within the cell. The inhibition of SNX17 disrupts this process, leading to alterations in receptor trafficking, which can impact various cellular functions, including cell adhesion, migration, and signal transduction.
The study of SNX17 Inhibitors provides valuable insights into the mechanisms of receptor trafficking and the broader implications of endosomal sorting on cellular homeostasis. By selectively inhibiting SNX17, researchers can dissect the pathways that depend on proper receptor recycling and explore how disruptions in these pathways affect cellular behavior. This is particularly relevant in understanding how cells regulate their surface receptor composition in response to environmental cues or during processes like cell migration and immune responses. Additionally, SNX17 Inhibitors offer a tool to investigate the interactions between SNX17 and other proteins involved in endosomal sorting, revealing the complex network of interactions that govern intracellular trafficking. Overall, SNX17 Inhibitors serve as a crucial resource for studying the dynamic processes of endocytosis and receptor recycling, contributing to a deeper understanding of cellular regulation and the maintenance of cellular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BMH-21 | 896705-16-1 | sc-507460 | 10 mg | $165.00 | ||
This compound also inhibits dynamin and can therefore disrupt endocytosis, potentially impacting the cycling of PSGL1 into endosomes. | ||||||
MRT67307 | 1190378-57-4 | sc-507433 | 10 mg | $234.00 | ||
MRT67307 inhibits TBK1 and IKKε, which play roles in endosomal trafficking, particularly in relation to autophagosome formation. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
By binding to actin, latrunculin A disrupts actin polymerization. The actin cytoskeleton is essential for many endocytic processes. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
This compound disrupts microtubule polymerization. Microtubules are crucial for vesicle transport and endosomal trafficking. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine inhibits clathrin-mediated endocytosis, potentially influencing endosomal trafficking routes. | ||||||
5-(N-Ethyl-N-isopropyl)-Amiloride | 1154-25-2 | sc-202458 | 5 mg | $104.00 | 20 | |
5-(N-Ethyl-N-isopropyl)amiloride is a potent inhibitor of macropinocytosis, a process closely related to endocytosis and endosomal trafficking. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts endosomal-lysosomal trafficking. This might influence SNX33 expression due to disrupted protein sorting. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-MA inhibits PI3K, known to affect autophagy. Given the relationship between endosomes and autophagosomes, SNX33 expression might be influenced. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Niclosamide inhibits SNX8 by interfering with its role in Wnt signaling, leading to the disruption of endosomal cargo sorting. | ||||||